It’s estimated that 90% of retail investors lose money. We help you beat those odds with concise research, education and more. Click here to see our offerings.
- A commercial-stage specialized diagnostics company that developed a platform designed to have superior accuracy in cancer as well as other disease areas
- Its host of products/services range from Cell universal culture media to COVID-19 testing (results as fast as 20-min)
- Leverages PRPO’s ICE COLD-PCR tech that empowers ultra testing sensitivity